Tocilizumab in COVID-19 Treatment: A Cost-Burden in Low- and Middle-Income Countries

AuthorMd Jahidul Hasanen
OrcidMd Jahidul Hasan [0000-0001-7038-6437]en
Issued Date2020-05-16en
AbstractThis article does not have an abstract.en
DOIhttps://doi.org/10.5812/ijhls.104480en
PublisherBrieflandsen
TitleTocilizumab in COVID-19 Treatment: A Cost-Burden in Low- and Middle-Income Countriesen
TypeLetteren

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijhls-6-2-104480.pdf
Size:
78.13 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF